MedTech News

.................... by Andrew Celentano

FiberSense Receives CE Mark for its New CGM System

FiberSense has announced that its Continuous Glucose Monitoring (CGM) System has obtained CE marking under Regulation (EU) 2017/745 as a Class IIb medical device. The system is intended for continuous monitoring of blood sugar levels and glucose trends in adults with diabetes.

Read More »

Sign up for Blog Updates